How can ophthalmologists better educate patients about the severity of DME progression?
Flagship dataset released to better understand type 2 diabetes development
NHS introduces OCT program to reduce annual hospital visits for patients with diabetes
Boehringer Ingelheim joins the Mary Tyler Moore Vision Initiative to combat vision loss from diabetes
Prevent Blindness recognizes November as Diabetes-Related Eye Disease Awareness Month
Gr8 Eye Movement data spotlights misconceptions and low awareness of serious retinal diseases among caregivers of older adults
EyePoint Pharmaceuticals reports positive 16-week interim results from Phase 2 VERONA trial of Duravyu for diabetic macular edema